Canopy Growth Corp. daily increases in the price of Toronto Stock Exchange (TSX) Canadian Exchange - IPO happened a few days ago. It is important to note - this is the first case where a company engaged in the medical marijuana got in the listing of one of the key markets in North America - on materials AMarkets.
The market value of the company at the moment - something around $ 300 million for the first time the company made an initial public offering in 2010, the TSX's Venture Exchange listed (not very prestigious market with simplified access, designed for small companies and start-ups).. The company before the release on the Toronto Stock Exchange was, so to speak, an outsider in the investment environment on Wall Street.
And the company has made a breakthrough here now - entered the serious investor. In the Canadian market is present about 30 licensed manufacturers of medical marijuana. Only these companies can grow and sell marijuana legally. In June, another Canadian company Tilray able to enter the Croatian market with their product - this is the first company, which the Canadian authorities gave the go-ahead to export cannabis. In July Canopy Growth was licensed to supply dry "potion" in Germany. Next in line - Brazil. The company will try to go to all the foreign markets, where cannabis is approved for use in the medical and pharmaceutical industry at the federal level.America, incidentally, in this case is not an option.
The decision of the authorities of Canada to extend the possibilities for the official medical marijuana business due to the desire to reduce the shadow market of cannabis. It is quite large and difficult to manage.